Literature DB >> 16301580

Incidence of polysaccharide storage myopathy: necropsy study of 225 horses.

B A Valentine1, B J Cooper.   

Abstract

Muscle samples were obtained at necropsy from 225 horses and ponies 1 year of age or older. Samples were processed in routine manner and were stained with hematoxylin and eosin and with periodic acid-Schiff for glycogen. Sections were examined for abnormal glycogen content and amylase-resistant complex polysaccharide and for chronic myopathic change (excessive fiber size variation, increase in number of internal nuclei). A total of 101 horses and ponies with lesions of polysaccharide storage myopathy were identified. Age of affected horses ranged from one to 30 years, with a mean of 14.7 years. Mean age of nonaffected horses was 12 years. Incidence of polysaccharide storage myopathy varied depending on breed; Thoroughbreds had the lowest (27%) and draft-related horses had the highest (86%) incidence. Chronic myopathic changes were more severe in polysaccharide storage myopathy-affected horses than in nonaffected horses. Results of this study indicate that polysaccharide storage myopathy is a common disorder of many breeds of horses and ponies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301580     DOI: 10.1354/vp.42-6-823

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  6 in total

1.  Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions.

Authors:  Eric Barrey; Elodie Mucher; Nicolas Jeansoule; Thibaut Larcher; Lydie Guigand; Bérénice Herszberg; Stéphane Chaffaux; Gérard Guérin; Xavier Mata; Philippe Benech; Marielle Canale; Olivier Alibert; Péguy Maltere; Xavier Gidrol
Journal:  BMC Vet Res       Date:  2009-08-07       Impact factor: 2.741

2.  Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis.

Authors:  Molly E McCue; Stephanie J Valberg; Michael B Miller; Claire Wade; Salvatore DiMauro; Hasan O Akman; James R Mickelson
Journal:  Genomics       Date:  2008-03-20       Impact factor: 5.736

3.  Allele copy number and underlying pathology are associated with subclinical severity in equine type 1 polysaccharide storage myopathy (PSSM1).

Authors:  Rosie J Naylor; Leanda Livesey; John Schumacher; Nicole Henke; Claire Massey; Kenny V Brock; Marta Fernandez-Fuente; Richard J Piercy
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

4.  Muscle glycogen concentrations and response to diet and exercise regimes in Warmblood horses with type 2 Polysaccharide Storage Myopathy.

Authors:  Zoë J Williams; Megan Bertels; Stephanie J Valberg
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

5.  Rhabdomyolysis and Acute Renal Failure Associated with Oxytetracycline Administration in Two Neonatal Foals Affected by Flexural Limb Deformity.

Authors:  Nicola Ellero; Francesca Freccero; Aliai Lanci; Maria Morini; Carolina Castagnetti; Jole Mariella
Journal:  Vet Sci       Date:  2020-10-22

6.  Commercial genetic testing for type 2 polysaccharide storage myopathy and myofibrillar myopathy does not correspond to a histopathological diagnosis.

Authors:  Stephanie J Valberg; Carrie J Finno; Marisa L Henry; Melissa Schott; Deborah Velez-Irizarry; Sichong Peng; Erica C McKenzie; Jessica L Petersen
Journal:  Equine Vet J       Date:  2020-10-29       Impact factor: 2.888

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.